Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Structural Protein Function01:56

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to form...
Structural Protein Function01:56

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to form...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.

Journal of thrombosis and haemostasis : JTH·2023
Same author

George J. Broze Jr., MD (3 August 1946-19 June 2019).

Journal of thrombosis and haemostasis : JTH·2019
Same author

Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity.

The Journal of experimental medicine·2019
Same author

Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model.

Blood·2019
Same author

Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.

Thrombosis and haemostasis·2015

Related Experiment Video

Updated: May 26, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Tissue factor pathway inhibitor: structure-function.

George J Broze1, Thomas J Girard

  • 1Division of Hematology, Washington University School of Medicine, St. Louis, MO 63110, USA. gbroze@dom.wustl.edu

Frontiers in Bioscience (Landmark Edition)
|December 29, 2011
PubMed
Summary

Tissue Factor Pathway Inhibitor (TFPI) regulates blood coagulation. Its primary isoform, TFPIalpha, is crucial for inhibiting Factor Xa and the Factor VIIa/tissue factor complex, highlighting its physiological importance.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Tissue Factor Pathway Inhibitor (TFPI) is a Kunitz-type proteinase inhibitor.
  • Alternative mRNA splicing results in three TFPI isoforms: TFPIalpha, TFPIdelta, and GPI-anchored TFPIbeta.
  • The endothelium is the primary source of TFPI, with TFPIalpha being the predominant human isoform.

Purpose of the Study:

  • To elucidate the structural domains responsible for TFPI's anticoagulant functions.
  • To investigate the mechanisms of TFPIalpha's interaction with coagulation factors.
  • To demonstrate the physiological significance of TFPI through genetic studies.

Main Methods:

  • Analysis of TFPI isoform structure and function.
  • Coagulation assays (one-stage and two-stage) to assess anticoagulant activity.
  • Studies using gene-disrupted mice to evaluate in vivo function.

Main Results:

  • The Kunitz-2 domain inhibits Factor Xa.
  • The Kunitz-1 domain inhibits the Factor VIIa/tissue factor complex.
  • TFPIalpha's anticoagulant activity involves Factor Xa inhibition (enhanced by Protein S) and Factor VIIa/tissue factor inhibition, depending on specific domains and assay systems.

Conclusions:

  • TFPIalpha is the main in vivo reservoir of TFPI, indirectly anchored to the endothelium.
  • Different domains of TFPIalpha contribute to its distinct inhibitory functions.
  • Gene-disruption studies confirm the critical physiological role of TFPI in hemostasis.